Gabon vs Sierra Leone: Incidence of tuberculosis
Incidence of tuberculosis over time
- Gabon
- Sierra Leone
How they compare
Sierra Leone currently reports 372 per 100,000 people against 371 per 100,000 people in Gabon, a difference of 1 per 100,000 people.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Sierra Leone ahead.
Gabon ranks 17th and Sierra Leone ranks 16th of 208 countries.
Across the 3 decades both report, Gabon averaged higher in 2 and Sierra Leone in 1.
Head to head by decade
| Decade | Gabon | Sierra Leone | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 375.7 per 100,000 people | 552.6 per 100,000 people | 176.9 per 100,000 people | Sierra Leone |
| 2010s | 468.4 per 100,000 people | 451.6 per 100,000 people | 16.8 per 100,000 people | Gabon |
| 2020s | 391 per 100,000 people | 387.6 per 100,000 people | 3.4 per 100,000 people | Gabon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher incidence of tuberculosis, Gabon or Sierra Leone?
- Sierra Leone, at 372 per 100,000 people against 371 per 100,000 people in Gabon as of 2024.
- What is the difference in incidence of tuberculosis between Gabon and Sierra Leone?
- 1 per 100,000 people, with Sierra Leone ahead.
- How many years of comparable data are there for Gabon and Sierra Leone?
- 25 years are reported by both, from 2000 to 2024.
- How do Gabon and Sierra Leone rank globally for incidence of tuberculosis?
- Gabon ranks 17th and Sierra Leone ranks 16th of 208 countries.
- Where does this data come from?
- Global Tuberculosis Report, World Health Organization (WHO), published as Incidence of tuberculosis (per 100,000 people). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Incidence of tuberculosis is the estimated number of new and relapse tuberculosis cases arising in a given year, expressed as the rate per 100,000 population. All forms of TB are included, including cases in people living with HIV. Estimates for all years are recalculated as new information becomes available and techniques are refined, so they may differ from those published previously.